Thomas Jefferson University

Ross Staudt

TitleDoctoral Student
InstitutionThomas Jefferson University
DepartmentAdministration - Thomas Jefferson University
Address1020 Locust Street
Philadelphia PA 19107
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. McCord JL, Han JYS, Staudt RE, Philp NJ, Snyder CM. Immune responses drive chorioretinitis and retinal pathology after neonatal CMV infection. Sci Adv. 2024 11 22; 10(47):eadn6379. PMID: 39565860.
      Citations:    
    2. Baybutt TR, Entezari AA, Caspi A, Staudt RE, Carlson RD, Waldman SA, Snook AE. CD8a Structural Domains Enhance GUCY2C CAR-T Cell Efficacy. Cancer Biol Ther. 2024 12 31; 25(1):2398801. PMID: 39315411.
      Citations:    
    3. Cao M, Carlson RD, Staudt RE, Snook AE. In vitro assays to evaluate CAR-T cell cytotoxicity. Methods Cell Biol. 2024; 183:303-315. PMID: 38548415.
      Citations:    
    4. Staudt RE, Carlson RD, Snook AE. Targeting gastrointestinal cancers with chimeric antigen receptor (CAR)-T cell therapy. Cancer Biol Ther. 2022 12 31; 23(1):127-133. PMID: 35129050.
      Citations:    
    5. Flickinger JC, Staudt RE, Singh J, Carlson RD, Barton JR, Baybutt TR, Rappaport JA, Zalewski A, Pattison A, Waldman SA, Snook AE. Chimeric adenoviral (Ad5.F35) and listeria vector prime-boost immunization is safe and effective for cancer immunotherapy. NPJ Vaccines. 2022 Jun 23; 7(1):61. PMID: 35739202.
      Citations:    
    Staudt's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (20)
    Explore
    _
    Co-Authors (4)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _